Checkpoint Inhibitor Therapy is a type of immunotherapy developed by James Allison. It works by blocking the immune checkpoints that cancer cells use to evade the immune system. This allows the immune system to recognize and attack cancer cells.
Unveiling the Revolutionary Researcher: The James P. Allison Intellect Challenge